Skip to main content

Cleartronic's (CLRI) Subsidiary Announces Expanded Use of ReadyOp(TM) by FDA

 

Clinical courses

 

Clinical research courses

BOCA Cleartronic, Inc., through its subsidiary ReadyOp Communications, Inc., announces that the US Food and Drug Administration (FDA) has expanded its use of ReadyOp as an integral part of their communications and incident response planning.

"The FDA began testing ReadyOp for their use in 2013. In 2014, they became a client and have continued to expand their use of ReadyOp since that time. This latest expansion includes using ReadyOp for their operation continuity planning. ReadyOp already serves as the continuity of operations (COOP) platform for several local and state government agencies, so this is in-line with the growth and actions we see in our other clients," stated Marc Moore, CEO of ReadyOp Communications, Inc.

Contingency and continuity planning are important for all organizations. ReadyOp provides an easy and efficient, yet powerful platform for organizations, government agencies, hospitals, universities and other groups for daily operations, to plan for special events and to plan and respond for incidents that may occur.

<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>